Citation

Wager TT, Pettersen BA, Schmidt AW, Spracklin DK, Mente S, Butler TW, Howard H, Lettiere DJ, Rubitski DM, Wong DF, Nedza FM, Nelson FR, Rollema H, Raggon JW, Aubrecht J, Freeman JK, Marcek JM, Cianfrogna J, Cook KW, James LC, Chatman LA, Iredale PA, Banker MJ, Homiski ML, Munzner JB, Chandrasekaran RY.: Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764). J Med Chem, Volume 54 (21), 2011

Authors

Aubrecht J, Banker MJ, Butler TW, Chandrasekaran RY., Chatman LA, Cianfrogna J, Cook KW, Freeman JK, Homiski ML, Howard H, Iredale PA, James LC, Lettiere DJ, Marcek JM, Mente S, Munzner JB, Nedza FM, Nelson FR, Pettersen BA, Raggon JW, Rollema H, Rubitski DM, Schmidt AW, Spracklin DK, Wager TT, Wong DF

Journal

J Med Chem

Year

2011

DOI

10.1021/jm200939b

PubMed

21928839

Machine-readable

REST APIRDF